Ampersand Capital Partners acquires CurTec, bolstering global growth in premium pharmaceutical packaging through innovation, sustainability, and strategic U.S. expansion.
Ampersand Capital Partners (“Ampersand”), a private equity firm focused on growth investments in the healthcare and life sciences sectors, has announced its acquisition of CurTec Group B.V. (“CurTec”), a Netherlands-based global leader in specialized packaging solutions. The acquisition was made in partnership with CurTec’s management and from the previous owner, Bencis Capital Partners (“Bencis”).
CurTec, headquartered in Rijen, Netherlands, is renowned for designing and manufacturing premium plastic packaging solutions that meet Good Manufacturing Practices (GMP) standards and United Nations (UN) certification requirements. These solutions are specifically tailored for the secure handling, transport, and storage of sensitive and high-value materials such as active pharmaceutical ingredients (APIs), excipients, and specialty chemical compounds. The company’s packaging products are widely used in highly regulated industries where hygiene, regulatory compliance, and durability are of utmost importance.
With production facilities located in both the Netherlands and the United States, and sales offices spanning Europe, North America, and Asia, CurTec serves a diverse and expanding international customer base. Recently, the company significantly increased its manufacturing capabilities by inaugurating a modern production facility in Westminster, South Carolina. This move is strategically aimed at catering to the growing North American market and complements CurTec’s existing European operations.
Bart van Berkel, CEO of CurTec, expressed enthusiasm about the partnership with Ampersand: “We are excited to welcome Ampersand as our new strategic partner. Their deep knowledge of the life sciences ecosystem and strong U.S. presence will be invaluable as we scale operations, pursue innovation, and grow our global footprint. Together, we aim to strengthen our position in existing markets and expand into adjacent sectors while staying committed to quality, innovation, and sustainability.”
Ampersand echoed this sentiment. Hidde Van Kerckhoven, Principal at the firm, noted, “CurTec is a trusted premium brand within the pharmaceutical industry, known for its exceptional standards and regulatory excellence. We are eager to support the management team in enhancing production capabilities, driving commercial growth, and executing on long-term strategic initiatives.”
Zoran van Gessel, Managing Partner at Bencis, reflected positively on their collaboration with CurTec: “It’s been a rewarding journey partnering with CurTec as they evolved into a global benchmark in regulated packaging. We are proud of the progress achieved alongside former CEO Fred Lammers and wish the CurTec team and Ampersand great success in the next stage of their growth.”
CurTec currently serves over 300 clients worldwide across the pharmaceutical, specialty chemical, and secure logistics sectors. With innovations like the Fold Pack – a sustainable, space-efficient solution that optimizes handling and logistics – the company continues to push the boundaries in sustainable GMP-compliant packaging, aligning closely with modern industry demands.
